Table 2 Cases where multistep strategy 2.2 is clinically superior to single-step strategy 2.2 and vice versa
From: Long range personalized cancer treatment strategies incorporating evolutionary dynamics
Number of drugs | Multistep > Single-step | Single-step > Multistep |
|---|---|---|
2 | 6199 (99.8 %) | 13 (0.2 %) |
3 | 18909 (99.99 %) | 2 (0.01 %) |